Akebia Therapeutics, Inc.AKBANASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, slight contraction.
Left:
||||
Free cash flow yield
Latest
-10.15%
↑ 59% above average
Average (9y)
-24.66%
Historical baseline
Range
High:14.07%
Low:-69.47%
CAGR
-4.6%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -10.15% | -0.9% |
| 2023 | -10.06% | +85.5% |
| 2022 | -69.47% | -3.0% |
| 2021 | -67.46% | -136.3% |
| 2020 | -28.55% | +19.1% |
| 2019 | -35.29% | -130.2% |
| 2018 | -15.33% | -71.6% |
| 2017 | -8.93% | -163.5% |
| 2016 | 14.07% | +191.1% |
| 2015 | -15.45% | - |